MedTrace Logo

Sahastara Remedy Extract Capsule in Primary Osteoarthritis of Clinical Trial Phase II

NCT04591795 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2020-10-19

No results posted yet for this study

Summary

To study efficacy and safety of Sahastara 95% ethanolic extract capsules compared to treatment Primary osteoarthritis for primary osteoarthritis, it was compared with diclofenac (Phase II).

Conditions

Interventions

DRUG

Sahastara remedy extract

The concentration of SHT extract is 100 mg per capsule

DRUG

Diclofenac

Diclofenac sodium, 25 mg enteric-coated tablets

Sponsors & Collaborators

  • Mr NARIN KAKATUM

    lead OTHER

Principal Investigators

  • Associate Professor Arunporn Itharat, Ph.D. · faculty of Medicine, Thammasat University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2020-10-13
Completion
2020-10-13

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04591795 on ClinicalTrials.gov